Con il lavoro dal titolo “Improvement and extension of anti-EGFR targeting in breast cancer therapy by integration with the Avidin-Nucleic-Acid-Nano-Assemblies”, pubblicato su «Nature Communications», si è dimostrato che, per trasportare un farmaco verso il tumore, è...
USP7 cooperates with NOTCH1 to drive the oncogenic transcriptional program in T cell leukemia Qi Jin, Carlos A. Martinez, Kelly M. Arcipowski, Yixing Zhu, Blanca Teresa Gutierrez Diaz, Kenneth K. Wang, Megan R. Johnson, Andrew G. Volk, Feng Wang, Jian Wu, Charles...
Preclinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma Renate De Smedt, Sofie Peirs, Julie Morscio, Filip Matthijssens, Juliette Roels, Lindy Reunes, Beatrice Lintermans, Steven Goossens, Tim...
Dual inhibition of PI3K/mTOR signaling in chemoresistant AML primary cells Jessika Bertacchini, Chiara Frasson, Francesca Chiarini, Daniele D’Avella, Benedetta Accordi, Laura Anselmi, Patrizia Barozzi, Fabio Forghieri, Mario Luppi, Alberto M. Martelli, Giuseppe...
During the 6th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma in Rotterdam (Netherlands), September 26-29, 2018 (http://cayanhl.pcrf-kids.org/ ), dr Federica Lovisa (Non Hodgkin Lymphoma – Molecular Diagnostics lab) was awarded...
